Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH - Concepedia

Concepedia

Publication | Open Access

Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH

DOI Full Paper Access

29

Citations

48

References

2018

Year

Jahidur Rashid, Ahmed Alobaida, Taslim A. Al‐Hilal, Samia Hammouda, Ivan F. McMurtry, Eva Nozik‐Grayck, Kurt R. Stenmark, Fakhrul Ahsan

Journal of Controlled Release

Molecular PharmacologyPharmaceutical SciencePharmacological StudyMedicinePpar-γ AgonistClinical PharmacologyPharmacotherapyInhaled FormulationPharmacologyDrug Discovery

References

	Year	Citations

Page 1

Page 1